Bilateral effect of unilateral bevacizumab injection in retinopathy of prematurity

JAMA Ophthalmol. 2013 Aug;131(8):1099-101. doi: 10.1001/jamaophthalmol.2013.400.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / pharmacokinetics
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / pharmacokinetics
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Combined Modality Therapy
  • Gestational Age
  • Humans
  • Infant, Extremely Low Birth Weight
  • Infant, Newborn
  • Intravitreal Injections
  • Laser Coagulation
  • Male
  • Retinal Neovascularization / drug therapy*
  • Retinal Neovascularization / surgery
  • Retinopathy of Prematurity / drug therapy*
  • Retinopathy of Prematurity / surgery
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab